Literature DB >> 10449688

Amiodarone protects cardiac myocytes against oxidative injury by its free radical scavenging action.

T Ide1, H Tsutsui, S Kinugawa, H Utsumi, A Takeshita.   

Abstract

BACKGROUND: Oxidative stress plays an important role in the pathophysiology of ischemic heart disease and heart failure, and antioxidants might be beneficial in the treatment of these patients. This study was performed to determine the scavenging effects of amiodarone on oxygen free radicals and its protective effects against oxygen radical-mediated injury in cardiac myocytes. METHODS AND
RESULTS: The formation of the radical spin adduct with hydroxy radical (.OH) in the presence of H(2)O(2) (10 mmol/L) and Fe(3+)-nitrilotriacetate (20 micromol/L) was monitored by electron paramagnetic resonance spectroscopy combined with a spin trapping agent, 5,5-dimethyl pyrroline-N-oxide (DMPO). Amiodarone decreased the intensity of the DMPO-OH signals in a dose-dependent manner (0.1 to 100 micromol/L), whereas other antiarrhythmia drugs such as disopyramide and atenolol had no such effects. Furthermore, amiodarone (10 micromol/L) protected intact adult canine cardiac myocytes against.OH-mediated myocyte injury, as assessed by the degree of morphological change from rod shape to the irreversible hypercontracture state during the exposure of cells to H(2)O(2) and Fe(3+) in vitro.
CONCLUSIONS: Amiodarone can protect cardiac myocytes against oxidative stress-mediated injury by directly scavenging oxygen free radicals. Antioxidant action of amiodarone might potentially contribute to the beneficial effects of this drug in the treatment of patients with ischemic heart disease and congestive heart failure.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10449688     DOI: 10.1161/01.cir.100.7.690

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  17 in total

1.  To add amiodarone or not: that is the question.

Authors:  Matthew Jason Zimmerman; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2008 Jan-Feb       Impact factor: 5.952

Review 2.  Heart failure and mitochondrial dysfunction: the role of mitochondrial fission/fusion abnormalities and new therapeutic strategies.

Authors:  Anne A Knowlton; Le Chen; Zulfiqar A Malik
Journal:  J Cardiovasc Pharmacol       Date:  2014-03       Impact factor: 3.105

3.  Pleiotropic actions of amiodarone: still puzzling after half a century.

Authors:  Jordi Heijman; Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-04-09       Impact factor: 3.000

Review 4.  Electron transport chain defects in heart failure.

Authors:  Jordi Casademont; Oscar Miró
Journal:  Heart Fail Rev       Date:  2002-04       Impact factor: 4.214

5.  Hypertrophic Cardiomyopathy: A Vicious Cycle Triggered by Sarcomere Mutations and Secondary Disease Hits.

Authors:  Paul J M Wijnker; Vasco Sequeira; Diederik W D Kuster; Jolanda van der Velden
Journal:  Antioxid Redox Signal       Date:  2018-04-11       Impact factor: 8.401

Review 6.  Mitochondrial dysfunction and oxidative stress in metabolic disorders - A step towards mitochondria based therapeutic strategies.

Authors:  Jasvinder Singh Bhatti; Gurjit Kaur Bhatti; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-11-09       Impact factor: 5.187

7.  Antioxidant activity of amiodarone on human lipoprotein oxidation.

Authors:  D Lapenna; G Ciofani; C Bruno; S D Pierdomenico; F Cuccurullo
Journal:  Br J Pharmacol       Date:  2001-07       Impact factor: 8.739

8.  Mitochondrial proteome remodeling in ischemic heart failure.

Authors:  Tingting Liu; Le Chen; Eunjung Kim; Diana Tran; Brett S Phinney; Anne A Knowlton
Journal:  Life Sci       Date:  2014-02-16       Impact factor: 5.037

9.  Efficacy of amiodarone treatment on cardiac symptom, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with beta-blocker therapy.

Authors:  Takuji Toyama; Hiroshi Hoshizaki; Ryotaro Seki; Naoki Isobe; Hitoshi Adachi; Shigeto Naito; Shigeru Oshima; Koichi Taniguchi
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

10.  Combined therapy with carvedilol and amiodarone is more effective in improving cardiac symptoms, function, and sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with carvedilol therapy alone.

Authors:  Takuji Toyama; Hiroshi Hoshizaki; Yuko Yoshimura; Shu Kasama; Naoki Isobe; Hitoshi Adachi; Shigeru Oshima; Koichi Taniguchi
Journal:  J Nucl Cardiol       Date:  2007-11-05       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.